Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
2016 · JAMA · 1,093 citations
https://doi.org/10.1001/jama.2016.16951
L
Leslie Cho
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
326
Papers
10.9K
Citations
46
h-index
118
i10-index
Leslie Cho is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Acute Myocardial Infarction Research & Antiplatelet Therapy and Cardiovascular Diseases. The author has an h-index of 46, co-authored 278 publications.
ORCID: 0000-0002-1190-1774Papers by this author
worksBempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
2023 · New England Journal of Medicine · 770 citations
https://doi.org/10.1056/nejmoa2215024
Increasing Participation of Women in Cardiovascular Trials
2021 · Journal of the American College of Cardiology · 142 citations
https://doi.org/10.1016/j.jacc.2021.06.022
Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients
2020 · Journal of the American Heart Association · 93 citations
https://doi.org/10.1161/jaha.120.019628
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)
2024 · JAMA · 69 citations
https://doi.org/10.1001/jama.2024.4504
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
2025 · American Heart Journal · 63 citations
https://doi.org/10.1016/j.ahj.2025.03.019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat